placeholder image
R. S. Neugebauer All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. 
    Lancet Reg Health Am. 2024
  • Association of cardiovascular outcomes and mortality with sustained long-acting insulin only vs long-acting plus short-acting insulin treatment. 
    JAMA network open. 2021
  • Comparison of mortality and major cardiovascular events among adults with type 2 diabetes using human vs analogue insulins. 
    JAMA network open. 2020
  • Accuracy of hemoglobin A1c imputation using fasting plasma glucose in diabetes research using electronic health records data
    2014
  • Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes. 
    Diabetes care. 2013
  • Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling. 
    Journal of Clinical Epidemiology. 2013
  • Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes. 
    Pharmacoepidemiology and Drug Safety. 2012
    • Chapter
  • Comparative effectiveness of adaptive treatment strategies. 
    Targeted learning in data science: causal inference for complex longitudinal studies (Springer series in statistics). 2018
    • Conference Poster
  • Impact of specific glucose-control strategies on microvascular outcomes in 58,000 adults with type 2 diabetes [poster]
    2013
    • Abstract
  • Impact of human versus analog insulins on occurrence of myocardial infarction [abstract]. 
    Diabetologia. 2017
    • presentations
    Contact
    full name
  • R. S. Neugebauer
    • Quick Info
     
    Collaboration